Paloma Partners Management CO Theravance Biopharma, Inc. Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $142,516 - $216,713	-9,636 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $198,887 - $295,728	9,636 New	9,636 $203,000
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $157,372 - $253,713	-10,088 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $227,686 - $283,977	10,088 New	10,088 $229,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.